104 related articles for article (PubMed ID: 780378)
1. Ripazepam (CI-683): double-blind comparison with placebo in anxious patients.
Schneyer JJ; Goodman LI; Borgen LA
J Clin Pharmacol; 1976 Jul; 16(7):377-83. PubMed ID: 780378
[TBL] [Abstract][Full Text] [Related]
2. SQ 65,396: a non-sedative anxiolytic?
Sakalis G; Sathananthan G; Collins P; Gershon S
Curr Ther Res Clin Exp; 1974 Aug; 16(8):861-3. PubMed ID: 4375017
[No Abstract] [Full Text] [Related]
3. A double-blind evaluation of fenfluramine in anxious somatizing neurotic medical clinic patients.
Raich WA; Rickels K; Raab E
Curr Ther Res Clin Exp; 1966 Jan; 8(1):31-3. PubMed ID: 4955145
[No Abstract] [Full Text] [Related]
4. A controlled trial of benzoctamine (Ba-30803) in neurotic anxiety.
Kellner R; Claghorn JL
J Clin Pharmacol J New Drugs; 1970; 10(5):342-8. PubMed ID: 4917355
[No Abstract] [Full Text] [Related]
5. Methodological considerations in evaluating antianxiety drugs.
Hollister LE
J Clin Pharmacol J New Drugs; 1970; 10(1):12-8. PubMed ID: 4903952
[No Abstract] [Full Text] [Related]
6. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.
Kingstone E; Villeneuve A; Kossatz I
Curr Ther Res Clin Exp; 1969 Mar; 11(3):106-14. PubMed ID: 4976238
[No Abstract] [Full Text] [Related]
7. Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study.
Predescu V; Ciurezu T; Timofte G; Roman I
Acta Psychiatr Scand; 1973; 49(1):15-27. PubMed ID: 4572167
[No Abstract] [Full Text] [Related]
8. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
Sugerman AA; Miksztal MW; Freymuth HW
J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717
[No Abstract] [Full Text] [Related]
9. SCH 12041. A new antianxiety agent.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1971 Feb; 13(2):107-10. PubMed ID: 4994212
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of a new minor tranquilizer Y-6047 for the treatment of sleep disturbance on the night before surgery. II. Comparison with diazepam in a double-blind controlled study].
Hagimori M; Mori Y; Kusumoto H; Aoki A; Tanimoto H
Masui; 1972 Mar; 21(3):243-50. PubMed ID: 4555737
[No Abstract] [Full Text] [Related]
11. Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.
Brauzer B; Goldstein BJ
J Clin Pharmacol New Drugs; 1972 Jul; 12(7):280-5. PubMed ID: 4557536
[No Abstract] [Full Text] [Related]
12. Controlled clinical trial of mepiprazole in irritable bowel syndrome.
Dotevall G; Groll E
Br Med J; 1974 Oct; 4(5935):16-8. PubMed ID: 4609545
[TBL] [Abstract][Full Text] [Related]
13. A comparison between diazepam, dixyrazine, opripramol and placebo in anxiety states.
Arfwidsson L; Arn L; Beskow J; Ottosson JO; Persson G
Acta Psychiatr Scand Suppl; 1971; ():19-32. PubMed ID: 4938880
[No Abstract] [Full Text] [Related]
14. [Clozapine in long-term therapy of chronic schizophrenia].
Gross H; Langner E; Pfolz H
Arzneimittelforschung; 1974 Jul; 24(7):987-9. PubMed ID: 4408041
[No Abstract] [Full Text] [Related]
15. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
Zwanikken GJ
Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
[No Abstract] [Full Text] [Related]
16. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of a new antianxiety agent Ba-30803.
Goldstein BJ; Weiner D
J Clin Pharmacol J New Drugs; 1970; 10(1):19-23. PubMed ID: 4905244
[No Abstract] [Full Text] [Related]
18. [Comparative double blind study of doxepine and medazepam in adolescents].
Moniot M; Misés R
Ann Med Psychol (Paris); 1971 Mar; 1(3):431-4. PubMed ID: 4934283
[No Abstract] [Full Text] [Related]
19. Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).
Linden M; Helmchen H; Müller-Oerlinghausen B
Arzneimittelforschung; 1988 Jun; 38(6):814-6. PubMed ID: 3178922
[TBL] [Abstract][Full Text] [Related]
20. Pyrazapon (CI-683): a new antianxiety agent.
Poschel BP; McCarthy DA; Chen G; Ensor CR
Psychopharmacologia; 1974 Feb; 35(3):257-71. PubMed ID: 4208323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
